New flu drug spin-off Atriva Therapeutics seeking funds to secure first clinical trial phase ow.ly/SVqdn @BioRegioSTERN
1
€7.1M for Swarm64's promising data processing platform from @AllianceVC, @targetpartners &@InvestinorAS ow.ly/SNFSD
Invoice trading platform @novicap secures $1.7M ow.ly/SzoZz
Mobile payment service @Daalder_ewallet wins €400K backing from @Keadyn; daalder = the old Dutch 2½ guilder coin ow.ly/Swo1W
The race among customer engagement platforms continues: @iAdvize raises €14M from @Iris_Capital @Bpifrance @alvencap ow.ly/Sw3Hn
Swiss VC @b_to_v announces €63M first closing of its third fund... and another €37M available via its angel network ow.ly/SkhTt
1
$2.6M seed round from @Northcapvc and angels for @GetLinkfire's nifty music link-marketing tool ow.ly/SjXUI
1
... which is dwarfed by @Amgen's $1.55B acquisition of 3-year-old cardio drug co Dezima; exit for Forbion, BGV, NSV ow.ly/SjWiC
Two Dutch biotech acquisitions in a row! First up @MDxHealth's $8.8M purchase of liquid biopsy company NovioGendix ow.ly/SjVJh
Collagen-based absorbable medical devices co Biom’Up bags €31.3M from @Bpifrance, @Gimv and Lundbeckfond Ventures ow.ly/RYmY4
... a day after it's competitor, UK mPOS company @sumup announces €10M round ow.ly/Rvrvk
Swedish mobile payments leader @izettle gets massive €60M Series D and introduces iZettle Advance ow.ly/Rvqio
Dutch media & online VC @Endeitcapital announces name change and new €107M fund ow.ly/Ru5KC
Flavour specialist Oxford Biotrans nets £2.5M Series A round from @ImperialInnova, @IPGroupplc and new investors ow.ly/QsWpT
Whoa... $320M for @Immunocore... They must be on to something with their TCR-based cancer drugs ow.ly/PJfqY
Email platform market inundated you say? @Iris_Capital @alvencap and Seventure think not as they put $11M in @mailjet ow.ly/PElkS
Credit risk data platform @CreditBenchmark pulls in $20M Series B round led by @balderton, joined by @IndexVentures ow.ly/PDK4p
Provider of solar encapsulant solutions NovoPolymers receives funds from corporate investor @DSM Venturing et al. ow.ly/PjX9M
